|
|
||||||||
The Journal of Immunology, Vol 155, Issue 11 5220-5226, Copyright © 1995 by American Association of Immunologists
ARTICLES |
PJ Tortolani, BK Lal, A Riva, JA Johnston, YQ Chen, GH Reaman, M Beckwith, D Longo, JR Ortaldo and K Bhatia
Lymphocyte Cell Biology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892, USA.
Members of the Janus family (JAK) of protein tyrosine kinases are critical enzymes in signaling pathways via hematopoietin receptors. We have cloned JAK3, which unlike other known family members (JAK1, JAK2, and TYK2) is preferentially expressed in hematopoietic cells but not in a variety of other cells. Functionally, JAK3 and JAK1 are coupled to the receptors for IL-2, IL-4, IL-7, IL-9, and IL-15 in T cells and NK cells. Because of the importance of IL-2, IL-4, and IL-7 in B cell physiology, we sought to determine whether JAK3 was also present in B lymphocytes and whether it was involved in signaling via cytokines that are important for B cell development and function. In this report, we demonstrate that JAK3 is expressed in normal human peripheral blood B cells at levels that are comparable to those in T cells. In addition, the levels were found to be markedly up-regulated following stimulation with staphylococcal protein A Cowan and anti-CD40 Abs. In addition, IL- 4 and IL-7 induced the rapid tyrosine phosphorylation of JAK3 and JAK1, and IL-4 activated both JAK3 and JAK1 phosphotransferase activity. JAK3 protein was also detected in immature B cell lines, but not in more well differentiated cell lines. Additionally, JAK3 was detected in lysates from bone marrow lymphoblasts of patients with B cell precursor acute lymphocytic leukemia and cell lines derived from human B cell lymphomas. Together, these data suggest that the regulation of JAK3 expression and activity is likely to be important in B cell development and function.
This article has been cited by other articles:
![]() |
H. Cheng, J. A. Ross, J. A. Frost, and R. A. Kirken Phosphorylation of Human Jak3 at Tyrosines 904 and 939 Positively Regulates Its Activity Mol. Cell. Biol., April 1, 2008; 28(7): 2271 - 2282. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aringer, S. R. Hofmann, D. M. Frucht, M. Chen, M. Centola, A. Morinobu, R. Visconti, D. L. Kastner, J. S. Smolen, and J. J. O'Shea Characterization and Analysis of the Proximal Janus Kinase 3 Promoter J. Immunol., June 15, 2003; 170(12): 6057 - 6064. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Verbsky, D. A. Randolph, L. P. Shornick, and D. D. Chaplin Nonhematopoietic Expression of Janus Kinase 3 Is Required for Efficient Recruitment of Th2 Lymphocytes and Eosinophils in OVA-Induced Airway Inflammation J. Immunol., March 1, 2002; 168(5): 2475 - 2482. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Atamas, I. G. Luzina, H. Dai, S. G. Wilt, and B. White Synergy Between CD40 Ligation and IL-4 on Fibroblast Proliferation Involves IL-4 Receptor Signaling J. Immunol., February 1, 2002; 168(3): 1139 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Revy, C. Hivroz, G. Andreu, P. Graber, C. Martinache, A. Fischer, and A. Durandy Activation of the Janus Kinase 3-STAT5a Pathway After CD40 Triggering of Human Monocytes But Not of Resting B Cells J. Immunol., July 15, 1999; 163(2): 787 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsumoto, C. Ra, K. Kawamoto, H. Sato, A. Itakura, J. Sawada, H. Ushio, H. Suto, K. Mitsuishi, Y. Hikasa, et al. IgE Hyperproduction Through Enhanced Tyrosine Phosphorylation of Janus Kinase 3 in NC/Nga Mice, a Model for Human Atopic Dermatitis J. Immunol., January 15, 1999; 162(2): 1056 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. B. Klaus, M. Holman, C. Johnson-Leger, J. R. Christenson, and M. R. Kehry Interaction of B cells with activated T cells reduces the threshold for CD40-mediated B cell activation Int. Immunol., January 1, 1999; 11(1): 71 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Corey and S. M. Anderson Src-Related Protein Tyrosine Kinases in Hematopoiesis Blood, January 1, 1999; 93(1): 1 - 14. [Full Text] [PDF] |
||||
![]() |
P. A. Goodman, L. B. Niehoff, and F. M. Uckun Role of Tyrosine Kinases in Induction of the c-jun Proto-oncogene in Irradiated B-lineage Lymphoid Cells J. Biol. Chem., July 10, 1998; 273(28): 17742 - 17748. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dalal, E. Arpaia, H. Dadi, S. Kulkarni, J. Squire, and C. M. Roifman Cloning and Characterization of the Human Homolog of Mouse Jak2 Blood, February 1, 1998; 91(3): 844 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pezet, F. Ferrag, P. A. Kelly, and M. Edery Tyrosine Docking Sites of the Rat Prolactin Receptor Required for Association and Activation of Stat5 J. Biol. Chem., October 3, 1997; 272(40): 25043 - 25050. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |